Companies are increasingly recognizing that diversity drives resilience, innovation, and success. This panel features Frances Arnold, Nobel Laureate, Generate:Biomedicines board member, and Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry at the California Institute of Technology; Sue Desmond-Hellmann, former CEO of the Bill and Melinda Gates Foundation; Cynthia Patton, General Counsel and Secretary of Tessera Therapeutics; and Flagship Pioneering Senior Partner Justine Levin-Allerhand, reflecting on their own experiences and where they see opportunities for impact through board engagement. More from Flagship @ JPM2024 here.
More from:
Human Health
Three Questions with Junaid Bajwa, Flagship Senior Partner, Head of UK, and Science Partner for Pioneering Intelligence
The Future of Genetic Medicines is Here
Three Questions with Hari Pujar, Founding President of Mirai Bio and Flagship Operating Partner
The Next Generation of Biologics Are Supranatural
Pioneering Profile
Q&A with Molly Gibson on Leading Company Origination
Letter of Support
